Phase 2 Hormone Receptor Positive Breast Carcinoma trials recruiting now

All Hormone Receptor Positive Breast Carcinoma trials, every phase

Phase 2 Hormone Receptor Positive Breast Carcinoma trials

• 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
  NCT07044310 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
  NCT06224673 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
  NCT04305834 · Phase: Phase 2 · Ages: 70 Years and older · Sex: All (male and female) · 6 locations
• Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
  NCT06486883 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 79 locations
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
  NCT04553770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.